Kara Gooding, PA-C, discusses the challenges of distinguishing benign pink lesions from potentially malignant skin cancers, drawing from her presentation at the DERM2026 NP/PA CME Conference. Through real-world case studies, she emphasizes the importance of evaluating lesion history, location, and symptoms such as bleeding or pain, particularly when dermoscopic findings are inconclusive. She also highlights the aggressive nature of Merkel cell carcinoma and the diagnostic challenges posed by amelanotic melanoma and other malignancies that can resemble common benign lesions.
Topics Covered
- Differentiating benign and malignant pink skin lesions
- Evaluating lesion history, location, and concerning symptoms
- Recognizing the limitations of dermoscopy in nonpigmented lesions
- Identifying Merkel cell carcinoma and its associated risk factors
- Understanding the diagnostic challenges of amelanotic melanoma
- Recognizing malignancies that mimic warts, nevi, and dermatofibromas
- Applying clinical case studies to improve diagnostic accuracy
Explore Related Resources
